scholarly journals Safety and efficacy of topical, fixed‐dose combination calcipotriene (0.005%) and betamethasone (0.064% as dipropionate) gel in adolescent patients with scalp and body psoriasis: a phase II trial

2020 ◽  
Vol 34 (5) ◽  
pp. 1098-1104 ◽  
Author(s):  
L.F. Eichenfield ◽  
D. Marcoux ◽  
M. Kurvits ◽  
M. Liljedahl
Sign in / Sign up

Export Citation Format

Share Document